278 related articles for article (PubMed ID: 21415493)
1. From cholera to enterotoxigenic Escherichia coli (ETEC) vaccine development.
Svennerholm AM
Indian J Med Res; 2011 Feb; 133(2):188-96. PubMed ID: 21415493
[TBL] [Abstract][Full Text] [Related]
2. Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant.
Holmgren J; Bourgeois L; Carlin N; Clements J; Gustafsson B; Lundgren A; Nygren E; Tobias J; Walker R; Svennerholm AM
Vaccine; 2013 May; 31(20):2457-64. PubMed ID: 23541621
[TBL] [Abstract][Full Text] [Related]
3. Strategies to overexpress enterotoxigenic Escherichia coli (ETEC) colonization factors for the construction of oral whole-cell inactivated ETEC vaccine candidates.
Tobias J; Svennerholm AM
Appl Microbiol Biotechnol; 2012 Mar; 93(6):2291-300. PubMed ID: 22350259
[TBL] [Abstract][Full Text] [Related]
4. Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study.
Lundgren A; Bourgeois L; Carlin N; Clements J; Gustafsson B; Hartford M; Holmgren J; Petzold M; Walker R; Svennerholm AM
Vaccine; 2014 Dec; 32(52):7077-84. PubMed ID: 25444830
[TBL] [Abstract][Full Text] [Related]
5. Preclinical Characterization of Immunogenicity and Efficacy against Diarrhea from MecVax, a Multivalent Enterotoxigenic E. coli Vaccine Candidate.
Seo H; Garcia C; Ruan X; Duan Q; Sack DA; Zhang W
Infect Immun; 2021 Jun; 89(7):e0010621. PubMed ID: 33875477
[TBL] [Abstract][Full Text] [Related]
6. Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea.
Ahmed T; Bhuiyan TR; Zaman K; Sinclair D; Qadri F
Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD009029. PubMed ID: 23828581
[TBL] [Abstract][Full Text] [Related]
7. Vaccination with Dukoral against travelers' diarrhea (ETEC) and cholera.
Jelinek T; Kollaritsch H
Expert Rev Vaccines; 2008 Jul; 7(5):561-7. PubMed ID: 18564011
[TBL] [Abstract][Full Text] [Related]
8. Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine.
Tokuhara D; Yuki Y; Nochi T; Kodama T; Mejima M; Kurokawa S; Takahashi Y; Nanno M; Nakanishi U; Takaiwa F; Honda T; Kiyono H
Proc Natl Acad Sci U S A; 2010 May; 107(19):8794-9. PubMed ID: 20421480
[TBL] [Abstract][Full Text] [Related]
9. Analysis of efficacy of CVD 103-HgR live oral cholera vaccine against all-cause travellers' diarrhoea in a randomised, double-blind, placebo-controlled study.
Leyten EM; Soonawala D; Schultsz C; Herzog C; Ligthelm RJ; Wijnands S; Visser LG
Vaccine; 2005 Oct; 23(43):5120-6. PubMed ID: 15982790
[TBL] [Abstract][Full Text] [Related]
10. Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli.
Roland KL; Cloninger C; Kochi SK; Thomas LJ; Tinge SA; Rouskey C; Killeen KP
Vaccine; 2007 Dec; 25(51):8574-84. PubMed ID: 18045752
[TBL] [Abstract][Full Text] [Related]
11. Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid protein.
Lundgren A; Leach S; Tobias J; Carlin N; Gustafsson B; Jertborn M; Bourgeois L; Walker R; Holmgren J; Svennerholm AM
Vaccine; 2013 Feb; 31(8):1163-70. PubMed ID: 23306362
[TBL] [Abstract][Full Text] [Related]
12. Induction of mucosal and systemic immune responses against the common O78 antigen of an oral inactivated ETEC vaccine in Bangladeshi children and infants.
Svennerholm AM; Qadri F; Lundgren A; Kaim J; Rahman Bhuiyan T; Akhtar M; Maier N; Louis Bourgeois A; Walker RI
Vaccine; 2022 Jan; 40(2):380-389. PubMed ID: 34772542
[TBL] [Abstract][Full Text] [Related]
13. Review on pathogenicity mechanism of enterotoxigenic Escherichia coli and vaccines against it.
Mirhoseini A; Amani J; Nazarian S
Microb Pathog; 2018 Apr; 117():162-169. PubMed ID: 29474827
[TBL] [Abstract][Full Text] [Related]
14. Progress and hurdles in the development of vaccines against enterotoxigenic Escherichia coli in humans.
Zhang W; Sack DA
Expert Rev Vaccines; 2012 Jun; 11(6):677-94. PubMed ID: 22873126
[TBL] [Abstract][Full Text] [Related]
15. A Systems Biology Approach Identifies B Cell Maturation Antigen (BCMA) as a Biomarker Reflecting Oral Vaccine Induced IgA Antibody Responses in Humans.
Mottram L; Lundgren A; Svennerholm AM; Leach S
Front Immunol; 2021; 12():647873. PubMed ID: 33828557
[TBL] [Abstract][Full Text] [Related]
16. Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial.
Clemens JD; Sack DA; Harris JR; Chakraborty J; Neogy PK; Stanton B; Huda N; Khan MU; Kay BA; Khan MR
J Infect Dis; 1988 Aug; 158(2):372-7. PubMed ID: 3042876
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of mucosal immune response following oral administration of enterotoxigenic Escherichia coli fimbriae (CFA/I) entrapped in liposomes in conjunction with inactivated whole-cell Vibrio cholerae vaccine.
Dima VF; Ionescu MD; Palade R; Balotescu C; Becheanu G; Dima SV
Roum Arch Microbiol Immunol; 2001; 60(1):27-54. PubMed ID: 11850896
[TBL] [Abstract][Full Text] [Related]
18. A review of the current status of enteric vaccines.
Levine MM; Noriega F
P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
[TBL] [Abstract][Full Text] [Related]
19. [Advances in new vaccines against human enterotoxigenic Escherichia coli--A review].
Xia P; Meng X; Zhu G
Wei Sheng Wu Xue Bao; 2016 Feb; 56(2):198-208. PubMed ID: 27373068
[TBL] [Abstract][Full Text] [Related]
20. Over-expression of major colonization factors of enterotoxigenic Escherichia coli, alone or together, on non-toxigenic E. coli bacteria.
Tobias J; Holmgren J; Hellman M; Nygren E; Lebens M; Svennerholm AM
Vaccine; 2010 Oct; 28(43):6977-84. PubMed ID: 20728524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
